Company Description
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.
It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
The company’s RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power.
RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery.
It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017.
RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
| Country | United States |
| Founded | 1997 |
| IPO Date | Jul 30, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 374 |
| CEO | Ronald Kurtz |
Contact Details
Address: 100 Columbia Aliso Viejo, California 92656 United States | |
| Phone | 949 521 7830 |
| Website | rxsight.com |
Stock Details
| Ticker Symbol | RXST |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $16.00 |
| CIK Code | 0001111485 |
| CUSIP Number | 78349D107 |
| ISIN Number | US78349D1072 |
| Employer ID | 94-3268801 |
| SIC Code | 3851 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ronald M. Kurtz M.D. | President, Chief Executive Officer and Director |
| Eric J. Weinberg | Co-President and Chief Commercial Officer |
| Shelley B. Thunen | Co-President and Chief Financial Officer |
| Dr. Ilya Goldshleger Ph.D. | Co-President and Chief Operating Officer |
| Rebecca Williston | Vice President of Accounting and Finance |
| Matt Haller Ph.D. | Chief Technology Officer |
| Oliver Moravcevic | Vice President of Investor Relations |
| Steve Everly | Senior Vice President of Sales of North America |
| Roy Freeman | Senior Vice President of Marketing and Professional Relations |
| Caroline Vaughn | Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 18, 2024 | 144 | Filing |
| Nov 15, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 144 | Filing |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | 10-Q | Quarterly Report |
| Nov 7, 2024 | 144 | Filing |
| Nov 7, 2024 | 8-K | Current Report |